Currency in
Last close As at 17/03/2023
—
— 0.00 (0.00%)
Market capitalisation
4m
Research: TMT
Osirium’s update on trading year to date confirms that it is seeing a return to pre-COVID levels of ordering. Nine new customers so far in Q1 at higher average contract values than a year ago mean that order intake is ahead of this period a year ago. We have upgraded our bookings and revenue forecasts for FY22 and incorporate the recent conditional £1m fund-raise.
Osirium Technologies |
Improving bookings outlook |
Contract wins |
Software & comp services |
3 March 2022 |
Share price performance
Business description
Next events
Analyst
Osirium Technologies is a research client of Edison Investment Research Limited |
Osirium’s update on trading year to date confirms that it is seeing a return to pre-COVID levels of ordering. Nine new customers so far in Q1 at higher average contract values than a year ago mean that order intake is ahead of this period a year ago. We have upgraded our bookings and revenue forecasts for FY22 and incorporate the recent conditional £1m fund-raise.
Year end |
Revenue (£m) |
EBITDA* |
EPS* |
DPS |
P/E |
EV/sales |
12/19 |
1.17 |
(2.15) |
(19.5) |
0.0 |
N/A |
3.3 |
12/20 |
1.43 |
(1.36) |
(12.9) |
0.0 |
N/A |
2.7 |
12/21e |
1.44 |
(1.67) |
(11.4) |
0.0 |
N/A |
2.7 |
12/22e |
1.73 |
(1.51) |
(6.9) |
0.0 |
N/A |
2.3 |
Note: *EBITDA and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Positive order momentum year to date
Osirium has announced that it has signed nine new customers so far this year, with four of the contracts of greater value than any deal signed in FY21. Osirium signed its largest ever number of new customers in FY21, benefiting from adoption of its secure back-up solution by a number of NHS trusts. This year’s new customers have signed up on higher average contract values, back to pre-COVID levels, with overall bookings ahead of this period a year ago. The company sees further opportunities in the NHS, both for new contracts and expansion of existing agreements, as well as good prospects in the higher education, retail and financial services sectors.
Upgrading order forecasts
We have revised our forecasts to reflect a more positive order outlook for FY22. We have increased our growth forecast for orders from 28% to 50%, noting that £1.5m worth of contracts are due for renewal this year. Our revenue forecast for FY22 increases 5%, reflecting the fact that bookings are typically for multi-year contracts, and the EBITDA loss reduces from £1.60m to £1.51m. We have also reflected the recent £1m fund-raise, assuming shareholders approve the issue of the remaining 69% of the placing at the general meeting on 7 March. Our end-FY22 net debt forecast reduces from £5.6m to £4.3m. The company indicated when the placing was announced that it intends another raise in H222.
Valuation: Bookings growth the key trigger
At 2.3x FY22e sales, Osirium is trading at a discount to peers on an EV/sales basis (the UK software sector is trading at 4.5x current year and 3.6x next year sales). Key to closing this gap will be evidence of sustained bookings momentum translating to revenue growth and progress towards break-even.
Changes to forecasts
Exhibit 1: Changes to forecasts
£'000s |
FY21e |
FY22e |
|||||||
Old |
New |
Change |
y-o-y |
Old |
New |
Change |
y-o-y |
||
Bookings |
1,568.7 |
1,568.7 |
0.0% |
0.0% |
2,007.9 |
2,353.0 |
17.2% |
50.0% |
|
Revenues |
1,437.3 |
1,437.3 |
0.0% |
0.2% |
1,644.7 |
1,734.3 |
5.4% |
20.7% |
|
EBITDA |
(1,668.1) |
(1,668.1) |
0.0% |
22.3% |
(1,604.4) |
(1,514.8) |
(5.6%) |
(9.2%) |
|
EBITDA margin |
-116.1% |
-116.1% |
0.0% |
-97.6% |
-87.3% |
(10.5%) |
|||
Normalised operating profit |
(3,293.9) |
(3,293.9) |
0.0% |
14.7% |
(3,390.7) |
(3,301.1) |
(2.6%) |
0.2% |
|
Normalised operating margin |
-229.2% |
-229.2% |
0.0% |
-206.2% |
-190.3% |
15.8% |
|||
Reported operating profit |
(3,293.9) |
(3,293.9) |
0.0% |
14.7% |
(3,390.7) |
(3,301.1) |
(2.6%) |
0.2% |
|
Reported operating margin |
-229.2% |
-229.2% |
0.0% |
-206.2% |
-190.3% |
15.8% |
|||
Normalised PBT |
(3,504.4) |
(3,504.4) |
0.0% |
13.2% |
(3,601.2) |
(3,511.6) |
(2.5%) |
0.2% |
|
Reported PBT |
(3,504.4) |
(3,504.4) |
0.0% |
13.2% |
(3,601.2) |
(3,511.6) |
(2.5%) |
0.2% |
|
Normalised net income |
(2,978.7) |
(2,978.7) |
0.0% |
18.9% |
(3,061.0) |
(2,984.8) |
(2.5%) |
0.2% |
|
Reported net income |
(2,978.7) |
(2,978.7) |
0.0% |
18.9% |
(3,061.0) |
(2,984.8) |
(2.5%) |
0.2% |
|
Normalised basic EPS (p) |
(11.43) |
(11.43) |
0.0% |
(11.1%) |
(10.43) |
(6.90) |
(33.8%) |
(39.6%) |
|
Normalised diluted EPS (p) |
(11.43) |
(11.43) |
0.0% |
(11.1%) |
(10.43) |
(6.90) |
(33.8%) |
(39.6%) |
|
Reported basic EPS (p) |
(11.43) |
(11.43) |
0.0% |
(11.1%) |
(10.43) |
(6.90) |
(33.8%) |
(39.6%) |
|
Gross cash |
205.0 |
205.0 |
0.0% |
319.2 |
628.8 |
97.0% |
|||
Net debt/(cash) |
2,500.3 |
2,500.3 |
0.0% |
145.0% |
5,588.7 |
4,279.1 |
(23.4%) |
71.1% |
Source: Edison Investment Research
Exhibit 2: Financial summary
£'000s |
2016 |
2017 |
2018 |
2019 |
2020 |
2021e |
2022e |
||
31-December |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
INCOME STATEMENT |
|||||||||
Revenue |
|
|
477.6 |
647.6 |
957.5 |
1,171.6 |
1,434.9 |
1,437.3 |
1,734.3 |
EBITDA |
|
|
(1,136.7) |
(1,609.4) |
(1,767.3) |
(2,152.1) |
(1,363.5) |
(1,668.1) |
(1,514.8) |
Normalised operating profit |
|
|
(1,725.6) |
(2,296.8) |
(2,674.8) |
(3,399.7) |
(2,872.4) |
(3,293.9) |
(3,301.1) |
Amortisation of acquired intangibles |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Exceptionals |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Share-based payments |
(96.9) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Reported operating profit |
(1,822.5) |
(2,296.8) |
(2,674.8) |
(3,399.7) |
(2,872.4) |
(3,293.9) |
(3,301.1) |
||
Net Interest |
9.7 |
4.2 |
(0.6) |
(52.2) |
(222.3) |
(210.5) |
(210.5) |
||
Joint ventures & associates (post tax) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Exceptionals |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Profit Before Tax (norm) |
|
|
(1,715.9) |
(2,292.6) |
(2,675.4) |
(3,451.9) |
(3,094.7) |
(3,504.4) |
(3,511.6) |
Profit Before Tax (reported) |
|
|
(1,812.8) |
(2,292.6) |
(2,675.4) |
(3,451.9) |
(3,094.7) |
(3,504.4) |
(3,511.6) |
Reported tax |
453.3 |
409.4 |
407.6 |
622.5 |
590.2 |
525.7 |
526.7 |
||
Profit After Tax (norm) |
(1,286.9) |
(1,883.2) |
(2,267.8) |
(2,829.4) |
(2,504.5) |
(2,978.7) |
(2,984.8) |
||
Profit After Tax (reported) |
(1,359.6) |
(1,883.2) |
(2,267.8) |
(2,829.4) |
(2,504.5) |
(2,978.7) |
(2,984.8) |
||
Minority interests |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Discontinued operations |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Net income (normalised) |
(1,286.9) |
(1,883.2) |
(2,267.8) |
(2,829.4) |
(2,504.5) |
(2,978.7) |
(2,984.8) |
||
Net income (reported) |
(1,359.6) |
(1,883.2) |
(2,267.8) |
(2,829.4) |
(2,504.5) |
(2,978.7) |
(2,984.8) |
||
Basic average number of shares outstanding (m) |
10 |
10 |
13 |
15 |
19 |
26 |
43 |
||
EPS - normalised (p) |
|
|
(12.38) |
(18.12) |
(18.14) |
(19.45) |
(12.85) |
(11.43) |
(6.90) |
EPS - normalised fully diluted (p) |
|
|
(12.38) |
(18.12) |
(18.14) |
(19.45) |
(12.85) |
(11.43) |
(6.90) |
EPS - basic reported (p) |
|
|
(13.08) |
(18.12) |
(18.14) |
(19.45) |
(12.85) |
(11.43) |
(6.90) |
Dividend (p) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Revenue growth (%) |
64.6 |
35.6 |
47.9 |
22.4 |
22.5 |
0.2 |
20.7 |
||
EBITDA Margin (%) |
-238.0 |
-248.5 |
-184.6 |
-183.7 |
-95.0 |
-116.1 |
-87.3 |
||
Normalised Operating Margin |
-361.3 |
-354.7 |
-279.4 |
-290.2 |
-200.2 |
-229.2 |
-190.3 |
||
BALANCE SHEET |
|||||||||
Fixed Assets |
|
|
1,178.8 |
1,812.1 |
2,360.2 |
3,124.4 |
3,487.3 |
3,967.4 |
4,326.9 |
Intangible Assets |
1,134.5 |
1,731.9 |
2,307.2 |
2,936.5 |
3,335.5 |
3,808.3 |
4,180.5 |
||
Tangible Assets |
44.3 |
80.2 |
52.9 |
187.9 |
151.9 |
159.1 |
146.4 |
||
Investments & other |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Current Assets |
|
|
3,953.7 |
1,646.4 |
3,134.6 |
4,837.3 |
2,300.8 |
1,150.9 |
1,647.8 |
Stocks |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Debtors |
380.9 |
622.6 |
748.0 |
982.4 |
818.4 |
945.8 |
1,019.1 |
||
Cash & cash equivalents |
3,572.8 |
1,023.8 |
2,386.6 |
3,854.9 |
1,482.4 |
205.0 |
628.8 |
||
Other |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Current Liabilities |
|
|
(648.5) |
(857.7) |
(1,170.3) |
(1,923.0) |
(2,143.7) |
(2,314.4) |
(2,963.2) |
Creditors |
(648.5) |
(857.7) |
(1,170.3) |
(1,889.1) |
(2,088.7) |
(2,284.4) |
(2,933.2) |
||
Tax and social security |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Short term borrowings |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Other |
0.0 |
0.0 |
0.0 |
(33.9) |
(55.0) |
(30.0) |
(30.0) |
||
Long Term Liabilities |
|
|
0.0 |
0.0 |
0.0 |
(2,422.4) |
(2,518.6) |
(2,731.1) |
(4,923.6) |
Long term borrowings |
0.0 |
0.0 |
0.0 |
(2,345.4) |
(2,502.9) |
(2,705.4) |
(4,907.9) |
||
Other long-term liabilities |
0.0 |
0.0 |
0.0 |
(77.0) |
(15.8) |
(25.8) |
(15.8) |
||
Net Assets |
|
|
4,483.9 |
2,600.8 |
4,324.5 |
3,616.3 |
1,125.8 |
72.8 |
(1,912.1) |
Minority interests |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Shareholders' equity |
|
|
4,483.9 |
2,600.8 |
4,324.5 |
3,616.3 |
1,125.8 |
72.8 |
(1,912.1) |
CASH FLOW |
|||||||||
Op Cash Flow before WC and tax |
(1,136.7) |
(1,609.4) |
(1,767.3) |
(2,152.1) |
(1,363.5) |
(1,668.1) |
(1,514.8) |
||
Working capital |
226.8 |
85.5 |
187.2 |
633.7 |
396.5 |
68.3 |
575.5 |
||
Exceptional & other |
0.0 |
0.0 |
0.0 |
0.0 |
14.0 |
0.0 |
0.0 |
||
Tax |
120.4 |
291.4 |
407.6 |
473.3 |
557.3 |
525.7 |
526.7 |
||
Net operating cash flow |
|
|
(789.4) |
(1,232.5) |
(1,172.5) |
(1,045.1) |
(395.7) |
(1,074.1) |
(412.5) |
Capex |
(968.0) |
(1,320.6) |
(1,455.7) |
(1,852.8) |
(1,875.1) |
(2,065.9) |
(2,125.8) |
||
Acquisitions/disposals |
0.0 |
0.0 |
0.0 |
0.4 |
3.3 |
0.0 |
0.0 |
||
Net interest |
9.7 |
4.2 |
(0.6) |
0.0 |
(56.5) |
(8.0) |
(8.0) |
||
Equity financing |
5,047.1 |
0.0 |
3,991.5 |
1,726.4 |
0.0 |
1,925.7 |
1,000.0 |
||
Dividends |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Other |
0.0 |
0.0 |
0.0 |
(60.6) |
(48.5) |
(55.0) |
(30.0) |
||
Net Cash Flow |
3,299.3 |
(2,549.0) |
1,362.8 |
(1,231.7) |
(2,372.5) |
(1,277.3) |
(1,576.3) |
||
Opening net (cash)/debt |
|
|
(273.5) |
(3,572.8) |
(1,023.8) |
(2,386.6) |
(1,509.5) |
1,020.5 |
2,500.3 |
FX |
0.0 |
0.0 |
0.0 |
(0.0) |
(0.0) |
0.0 |
0.0 |
||
Other non-cash movements |
0.0 |
0.0 |
(0.0) |
354.6 |
(157.4) |
(202.5) |
(202.5) |
||
Closing net (cash)/debt |
|
|
(3,572.8) |
(1,023.8) |
(2,386.6) |
(1,509.5) |
1,020.5 |
2,500.3 |
4,279.1 |
Source: Osirium, Edison Investment Research
|
|
Research: TMT
Following its strategic review, announced in August 2021, CI Games has today announced that it is considering a dual listing in London. It has appointed Berenberg as its financial adviser in relation to the potential listing and announced the appointment of David Broderick (ex Keywords Studios and Ryanair) as CFO. As a domestically held stock, CI Games trades on 1.7x EV/EBITDA and 2.7x P/E in FY23e, well below its peer group. If it can successfully launch the next Sniper: Ghost Warrior game and Lords of the Fallen 2 in FY23 to establish a broad-based portfolio, both our DCF analysis and peer multiples indicate the potential for significant upside as a reward for early investors in this growth story.
Get access to the very latest content matched to your personal investment style.